Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: Possible role of its antioxidant action

Current Vascular Pharmacology

Volumn 8, Issue 1, 2010, Pages 59-63

  Ando, Katsuyuki ^a   Matsui, Hiromitsu ^a   Fujita, Megumi ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Excess salt; Insulin resistance; Potassium supplement; Reactive oxygen species; Sympathetic nervous system

Indexed keywords

ADENOSINE TRIPHOSPHATASE; POTASSIUM; REACTIVE OXYGEN METABOLITE;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; DIASTOLIC DYSFUNCTION; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; OXIDATIVE STRESS; POTASSIUM INTAKE; REVIEW; VASCULAR DISEASE;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; HUMANS; HYPERTENSION; INSULIN RESISTANCE; OXIDATIVE STRESS; POTASSIUM, DIETARY; REACTIVE OXYGEN SPECIES; SODIUM CHLORIDE, DIETARY; SODIUM, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 77949539069     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016110790226561     Document Type: Review

References (58)

1. Fujita T, Ando K, Ogata E. Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Hypertension 1990; 16: 235-44.
2. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: Rationale of salt restriction target level for the management of hypertension. Hypertens Res 2007; 30: 879-86.
3. MacGregor GA. Blood pressure: importance of the kidney and the need to reduce salt intake. Am J Kidney Dis 2001; 37(suppl 2): S34-8.
4. Sasaki N. Relation of urinary findings, especially sodium potassium ratio, to blood pressure levels in the northeast of Japan. Med Biol 1956; 39: 182-7 (In Japanese).
5. Fujita T, Noda H, Ando K. Sodium susceptibility and potassium effects in young patients with borderline hypertension. Circulation 1984; 69: 468-76.
6. Fujita T, Ando K. Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension 1984; 6: 184-92.
7. Fujita T, Sato Y. Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kidney Int 1983; 24: 731-9.
8. Sato Y, Ando K, Ogata E, Fujita T. High potassium diet attenuates salt-induced acceleration of hypertension in SHR. Am J Physiol Regul Integr Comp Physiol 1991; 260: R21-6.
9. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al.; for the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10.
10. Tobian L, Lange J, Ulm K, Wold L, Iwai J. Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension 1985; 7: I110-4.
11. Ma G, Srivastava NT, Anderson PG, Grady AW, Skelton KN, Lyle K, et al. Elevated potassium intake inhibits neointimal proliferation in the swine coronary artery. Am J Hypertens 2001; 14: 879-86.
12. Ma G, Young DB, Clower BR, Anderson PG, Lin H, Abide AM. High potassium intake inhibits neointima formation in the rat carotid artery balloon injury model. Am J Hypertens 2000; 13: 1014-20.
13. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, et al. Protective effect of potassium against the hypertensive cardiac dysfunction. Hypertension 2006; 48: 225-31.
14. Kido M, Ando K, Onozat ML, Tojo A, Yoshikawa M, Ogita T, et al. Protective effect of dietary potassium against the vascular injury in salt-sensitive hypertension. Hypertension 2008; 51; 225-31.
15. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension 1999; 34: 724-8.
16. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996; 94: 690-7.
17. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-9.
18. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980; 69: 334-44.
19. Fujita T, Sato Y, Ando K. Role of sympathetic nerve activity and natriuresis in the antihypertensive actions of potassium in NaCl hypertension. Jpn Circ J 1983; 47: 1227-31.
20. Fujita T, Sato Y. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats. Am J Physiol Renal Physiol 1984; 246: F670-5.
21. Saum WR, Ayachi S, Brown AM. Actions of sodium and potassium ions on baroreceptors of normotensive and spontaneously hypertensive rats. Circ Res 1977; 1: 768-74.
22. Lawton WJ, Fitz AE, Anderson EA, Sinkey CA, Coleman RA. Effect of dietary potassium on blood pressure, renal function, muscle sympathetic nerve activity, and forearm vascular resistance and flow in normotensive and borderline hypertensive humans. Circulation 1990; 81: 173-84.
23. Nakamura K, Gerold M, Thoenen H. Experimental hypertension of the rat: reciprocal changes of norepinephrine turnover in heart and brain-stem. Naunyn Schmiedebergs Arch Pharmakol 1971; 268: 125-39.
24. Sato Y, Ando K, Ogata E, Fujita T. High potassium intake attenuates antinatriuretic response to air stress in DOCA-salt rats. Am J Physiol Heart Circ Physiol 1991; 260: R941-5.
25. Ogihara T, Asano T, Ando K, Sakoda H, Anai M, Shojima N, et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002; 40: 83-9.
26. Fujita T. Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol Dial Transplant 2007; 22: 3102-7.
27. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000; 35: 864-8.
28. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005; 28: 2823-31.
29. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 1983; 32: 106-11.
30. Shimosawa T, Sibagki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-11.
31. Kawai J, Ando K, Tojo A, Shimosawa T, Takahashi K, Onozato ML, et al. Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation 2004; 109: 1147-53.
32. Kido M, Ando K, Oba S, Fujita T. Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats. Hypertens Res 2005; 28: 1009-15.
33. Meng S, Roberts LJ, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and - resistant rats. Am J Physiol Regul Integ Comp Physiol 2002; 283: R732-8.
34. Fujita M, Kuwaki T, Ando K, Fujita T. Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension 2005; 45: 1165-72.
35. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ Res 2004; 94: 402-9.
36. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 2004; 95: 210-6.
37. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005; 46: 533-9.
38. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in saltsensitive hypertension. Hypertension 2007; 50: 360-7.
39. Ogihara T, Asano T, Fujita T. Contribution of salt intake to insulin resistance associated with hypertension. Life Sci 2003; 73: 509-23.
40. Ogihara T, Asano T, Ando K, Chiba Y, Sakoda H, Anai M, et al. Angiotensin II-induced insulin resistance is associated with enhanced insulin-signaling. Hypertension 2002; 40: 872-9.
41. Xing G, Shimosawa T, Ogihara T, Matsui H, Itakura K, Quingyou X, et al. Angiotensin II-induced insulin resistance is enhanced in adrenomedullin-deficient mice. Endocrinology 2004; 145: 3647-51.
42. Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472-7.
43. Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, et al. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 2004; 47: 794-805.
44. Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, et al. Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine. Biochem J 2000; 349: 579-86.
45. Paolisso G, Balbi V, Volpe C, Varricchio G, Gambardella A, Saccomanno F, et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995; 14: 387-92.
46. Paolisso G, Di Maro G, Galzerano D Cacciapuoti F, Varricchio G, Varricchio M, et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994; 59: 1291-6.
47. Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1996; 18: 659-73.
48. Yang BC, Li DY, Weng YF, lynch J, Wingo CS, Metha JL. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. Am J Physiol Heart Circ Physiol 1998; 274: H1955-61.
49. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003; 41: 422-30.
50. MacCabe RD, Bakarich MA, Srivastava K, Young DB. Potassium inhibits free radical formation. Hypertension 1994; 24: 77-82.
51. Sohn HY, Keller M, Gloe T, Morawietz H, Rueckschloss U, Pohl U. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells. J Biol Chem 2000; 275: 18745-50.
52. McCarty MF. The small G-protein Rac mediates depolarizationinduced superoxide formation in human endothelial cells. Med Hypothesis 2005; 64: 854-63.
53. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006; 47: 488-95.
54. Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 2000; 275: 27838-44.
55. Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci 2006; 110: 243-53.
56. Landa DM, Boegehold MA. Effect of a high salt diet on microvascular antioxidant enzymes. J Vas Res 2002; 39: 41-50.
57. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, et al.; HOPE and HOPE-TOO trial investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-47.
58. Versari D, Daghini E, Rodriguez-Porcel M, Sattler K, Galili O, Pilarczyk K, et al. Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension 2006; 47: 475-81.